SynthesisJournal of global health2025
Prevalence of osteoporosis and associated factors among Chinese adults: a systematic review and modelling study.
Synthesis in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prediction models for subsequent vertebral fractures after percutaneous vertebroplasty or kyphoplasty: a systematic review and critical appraisal.BMC musculoskeletal disorders · 2026Pooled it
- Prevalence and Associated Risk Factors of Osteoporosis in Community-Dwelling Older Adults in China: A Cross-Sectional Study of 2533 Participants.Medical science monitor : international medical journal of experimental and clinical research · 2026Article
- Quality and reliability of osteoporosis-related health information on short-video platforms: a multi-source cross-sectional study.BMC public health · 2026Article
- Extracellular Vesicles Derived from Resveratrol-Treated BMSCs Promote the Repair of Bone Defects in Osteoporotic Rats.Stem cell reviews and reports · 2026Article
- Optimal Resistance Exercise Strategies for Improving Bone Mineral Density in Middle-Aged and Older Adults: A Network Meta-Analysis Based on Exercise Intensity and Frequency.Calcified tissue international · 2026Article
- Machine learning prediction for menopause women with low bone mass: a multicenter and retrospective study.Scientific reports · 2026Article
- Combination of artificial intelligence and chest computed tomography to assess bone mineral density.Skeletal radiology · 2026Article
- Design, Synthesis and Biological Evaluation of Novel Furanocoumarin Derivatives: Validation of Anti-Osteoporotic Efficacy In Vitro and In Vivo.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Identification of key predictors of postmenopausal osteoporosis from routine clinical indicators using explainable machine learning.PloS one · 2026Article
- Trends in mortality with osteoporosis recorded as the underlying cause of death among adults aged 65 years and older in the United States, 1999-2024.Frontiers in medicine · 2026Article
- Adiposity indices and bone health amongst Malaysian adults: Evidence from a cross-sectional study.Experimental and therapeutic medicine · 2026Article
- Association between kinesiophobia and bone mineral density in hospitalized older adults with osteoporosis: a cross-sectional study.Frontiers in endocrinology · 2026Article
- Age-specific association between moderate-to-vigorous physical activity and bone health: insights from a universal pDXA screening cohort in rural China.Frontiers in endocrinology · 2026Article
- Exploratory multi-omics analysis of gut microbiota and fecal metabolites in relation to serum S-equol levels in older adults with osteoporosis from a tropical community: a pilot study.Frontiers in nutrition · 2026Article
- Dietary Index for Gut Microbiota and Osteoporosis Risk in Chinese Postmenopausal Women: A Case-Control Study.International journal of women's health · 2026Article
- Adiposity-lipid-glycemic clusters as potential warning signals of bone mass reduction in Asia's largest urban communities - based bone health assessment via ultrasound.Lipids in health and disease · 2025Article
- Face2Bone explainable AI model predicts osteoporosis risk from facial images in proof of concept study.Scientific reports · 2025Observational
- [Attributable disease burden of low bone mineral density related fractures in people over 50 years old from 1990 to 2023 in China].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2025Article
- Coronal CT Attenuation Measurement for Osteoporosis Screening at the Proximal Femur: A Comparative Study with the Axial Approach.Diagnostics (Basel, Switzerland) · 2025Article
- An evidence-informed Delphi study of ambulatory care sensitive conditions in China: a policy tool to assess primary care performance.The Lancet regional health. Western Pacific · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoporosis is a degenerative disease of bone metabolism. The epidemiology of osteoporosis varies by age, sex, and geography. There is a lack of information on the prevalence of osteoporosis among Chinese adults. In this study, we aimed to estimate the prevalence of osteoporosis among Chinese adults by age, sex, and skeletal sites and explore the main associated factors. Methods: We searched six bibliographic databases to identify epidemiological studies that reported the prevalence of osteoporosis among Chinese adults published between January 1990 and February 2022. We applied a multilevel mixed-effects meta-regression to estimate the age-specific prevalence of osteoporosis. We presented the age-specific prevalence of osteoporosis by sex, diagnostic criteria (World Health Organization (WHO) and Chinese (CHN) diagnostic criteria), and specific skeletal site (the lumbar spine, femoral neck, and ward's triangle). We used the population data from the seventh National Census of Mainland China to estimate the number of Chinese adults with osteoporosis in 2020. Major associated factors for osteoporosis were pooled by a random-effects meta-analysis. We also estimated the regional prevalence and cases of osteoporosis among 31 provinces in mainland China in 2020 using an 'associated factor-based model.' Results: We included 129 articles in this systematic review and modelling study. 32 were based on the WHO diagnostic criteria and 17 on the CHN diagnostic criteria. Additionally, we included 83 articles in the associated factor analysis. The prevalence of osteoporosis increased with age and was consistently higher in females than males, regardless of diagnostic criteria and skeletal sites. Whether based on the WHO criteria (13.54%, 95% confidence interval (CI) = 10.25, 18.11) or the CHN criteria (29.49%, 95% CI = 18.29, 43.5), the prevalence of osteoporosis among Chinese adults aged 20-89 years in 2020 was highest when measuring the ward's triangle, which translated to 145.86 million (95% CI = 110.41, 195.03) and 317.54 million (95% CI = 196.95, 468.47) affected adults, respectively. The prevalence of osteoporosis was the highest in Northeast China under both the WHO criteria (15.50%, 95% CI = 11.78, 20.59) and the CHN criteria (32.36%, 95% CI = 20.33, 46.8), with the ward being the measured skeletal site. Marital status, current smoking, underweight, hypertension, fracture history, longer menopause years and menopause were positively associated with osteoporosis. Conclusions: Osteoporosis remains a significant public health concern in China, particularly among females and the elderly. Meanwhile, the prevalence of osteoporosis varies considerably by region, skeletal site and diagnostic criteria. It is essential to establish clear and unified diagnostic criteria and implement high-quality epidemiological studies for osteoporosis in China. Additionally, targeted preventive strategies that focus on individuals with characteristics associated with osteoporosis are required to mitigate the impact of this condition. Registration: PROSPERO: CRD42024564441.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.